"Phenylalanine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE.
Descriptor ID |
D010649
|
MeSH Number(s) |
D12.125.072.050.685 D12.125.142.666
|
Concept/Terms |
Phenylalanine- Phenylalanine
- Phenylalanine, L-Isomer
- L-Isomer Phenylalanine
- Phenylalanine, L Isomer
- L-Phenylalanine
|
Below are MeSH descriptors whose meaning is more general than "Phenylalanine".
Below are MeSH descriptors whose meaning is more specific than "Phenylalanine".
This graph shows the total number of publications written about "Phenylalanine" by people in this website by year, and whether "Phenylalanine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2017 | 4 | 5 | 9 |
2018 | 1 | 5 | 6 |
2019 | 1 | 0 | 1 |
2020 | 0 | 2 | 2 |
2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Phenylalanine" by people in Profiles.
-
Exposure of human intestinal epithelial cells and primary human hepatocytes to trypsin-like serine protease inhibitors with potential antiviral effect. J Enzyme Inhib Med Chem. 2021 Dec; 36(1):659-668.
-
Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows. Clin Chem Lab Med. 2021 11 25; 59(12):1891-1905.
-
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. J Virol. 2021 07 26; 95(16):e0061721.
-
The Impact of the First 2020 COVID-19 Lockdown on the Metabolic Control of Patients with Phenylketonuria. Nutrients. 2021 Jun 12; 13(6).
-
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells. ACS Chem Biol. 2021 04 16; 16(4):642-650.
-
Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions. mBio. 2021 03 30; 12(2).
-
Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat Struct Mol Biol. 2020 12; 27(12):1202-1208.
-
Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1. J Transl Med. 2020 08 31; 18(1):329.
-
Functional Characterization of Knock-In Mice Expressing a 12/15-Lipoxygenating Alox5 Mutant Instead of the 5-Lipoxygenating Wild-Type Enzyme. Antioxid Redox Signal. 2020 01 01; 32(1):1-17.
-
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity. Eur J Heart Fail. 2019 04; 21(4):519-528.